Brachytherapy and anterior segment imaging in iris melanoma
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Post-publication record
- Nature
- Retraction
- Reason
- Duplication of/in Article;
- Date
- 3/5/2018 0:00
- Flagged by OpenAlex?
- Yes
Source: Retraction Watch, joined by DOI. OpenAlex records retraction as is_retracted, a boolean over a state space with at least four values, so it cannot express an expression of concern, a correction or a reinstatement — it reports them as false, which reads as “fine”.
Abstract
Ultrasound biomicroscopy (UBM) remains a potent tool in the diagnosis and characterization of uveal lesions. In the setting of malignancy, it can confirm both placement of and response to brachytherapy. We present a case of iris melanoma with aggressive BAP-1 mutation, treated successfully with I-131 brachytherapy which was both characterized and followed with UBM and thereafter discuss the current state of these modalities.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Oman Journal of Ophthalmology
- Topic
- Ocular Oncology and Treatments
- Field
- Medicine
- Canadian institutions
- University of TorontoDalhousie University
- Funders
- —
- Keywords
- Ultrasound biomicroscopyMedicineBrachytherapyMalignancyIRIS (biosensor)RadiologyMelanomaUltrasoundOphthalmologyPathologyRadiation therapyCancer researchComputer scienceArtificial intelligence
- Has abstract in OpenAlex
- yes